Gilead Sciences
GILD
#128
Rank
โ‚ฌ129.50 B
Marketcap
104,37ย โ‚ฌ
Share price
-2.26%
Change (1 day)
17.96%
Change (1 year)

Revenue for Gilead Sciences (GILD)

Revenue in 2025 (TTM): โ‚ฌ26.06 Billion

According to Gilead Sciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ25.03 Billion. In 2024 the company made a revenue of โ‚ฌ27.63 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ24.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gilead Sciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ26.06 B-5.67%
2024 โ‚ฌ27.63 B12.65%
2023 โ‚ฌ24.52 B-3.56%
2022 โ‚ฌ25.43 B5.48%
2021 โ‚ฌ24.11 B20.12%
2020 โ‚ฌ20.07 B0.16%
2019 โ‚ฌ20.03 B3.61%
2018 โ‚ฌ19.34 B-11.11%
2017 โ‚ฌ21.75 B-24.69%
2016 โ‚ฌ28.89 B-3.21%
2015 โ‚ฌ29.85 B45.86%
2014 โ‚ฌ20.46 B152.31%
2013 โ‚ฌ8.11 B10.58%
2012 โ‚ฌ7.33 B13.6%
2011 โ‚ฌ6.45 B8.04%
2010 โ‚ฌ5.97 B22.12%
2009 โ‚ฌ4.89 B28.22%
2008 โ‚ฌ3.81 B31.74%
2007 โ‚ฌ2.89 B26.32%
2006 โ‚ฌ2.29 B33.94%
2005 โ‚ฌ1.71 B75.35%
2004 โ‚ฌ0.97 B41.66%
2003 โ‚ฌ0.68 B54.37%
2002 โ‚ฌ0.44 B68.7%
2001 โ‚ฌ0.26 B25.82%
2000 โ‚ฌ0.21 B25.26%
1999 โ‚ฌ0.16 B224.09%
1998 โ‚ฌ51.82 M53.75%
1997 โ‚ฌ33.7 M19.4%
1996 โ‚ฌ28.23 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ30.96 B 23.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ10.09 B-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.33 B 105.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ3.69 B-85.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.66 B-65.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.03 B 115.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.31 B 216.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.14 B 104.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.28 B 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA